Hypoloc plus HCT

Quick links to important sections

Hypoloc plus HCT

Method of action: Antihypertensive, Diuretic

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hypoloc plus HCT

Property Description
Active Ingredients Nebivolol, Hydrochlorothiazide (HCT)
Form Fixed-dose combination oral tablet (synthetic)
Pharmacological Class Antihypertensive agent (Third-generation Beta-blocker and Thiazide Diuretic)
Common Use Management of Essential Hypertension (high blood pressure)
Origin Synthetic

What is Hypoloc plus HCT and What is its Purpose?

Hypoloc plus HCT is a fixed-dose combination product formulated as a synthetic, prescription-only tablet used for the comprehensive management of essential hypertension (high blood pressure). It is broadly categorized as an antihypertensive agent whose primary function is to achieve simultaneous control over elevated blood pressure using two distinct pharmacological approaches, a method recognized and supported by pharmacological research. Combining these agents is a standard strategy for treating high blood pressure.

The medication is intended for adult patients whose high blood pressure requires combination therapy to reach a safer therapeutic range, often used when initial monotherapy proves insufficient. As a single oral tablet, it integrates the necessary treatments into one unit, ensuring that the two essential active ingredients are administered together to effectively address the multifactorial causes of hypertension.


Composition and Pharmacological Class of Hypoloc plus HCT

The medication contains two distinct active ingredients: Nebivolol and Hydrochlorothiazide (HCT). This formulation effectively couples a cardiospecific agent with a volume-reducing agent to enable comprehensive blood pressure control.

Nebivolol is classified as a highly selective third-generation beta-blocker, which acts as a selective beta-1 adrenergic receptor antagonist. Hydrochlorothiazide is a different class of synthetic medication known as a thiazide diuretic. The combination of a beta-blocker and a diuretic is a recognized strategy for blood pressure reduction, as the combined classes are established by health authorities as an effective therapy. The integration of these two agents from different pharmacological classes is an evidence-based strategy employed when a single type of drug is insufficient to control a patient's blood pressure.


Unique Features of the Combination

The key differentiating feature of the Nebivolol component is its vasodilatory property, setting it apart from older, non-vasodilating beta-blockers. The advantage of utilizing Hypoloc plus HCT as a fixed-dose combination is the simplification of the long-term treatment regimen for individuals managing hypertension. This specific pharmaceutical form ensures that the complementary effects of the beta-blocker (Nebivolol) and the thiazide diuretic (Hydrochlorothiazide) are always delivered simultaneously, providing a consistent foundation for lowering high blood pressure by addressing both cardiac output (rate and force) and the systemic fluid volume in a single, streamlined unit.

Regulatory References

  1. Nebivolol FDA Label (via NIH)
  2. Hypoloc Plus HCT Package Leaflet (HPRA)

What side effects are possible with Hypoloc plus HCT?

Possible Side Effects and Safety Information

Regulatory authorities classify the possible side effects of this fixed-dose combination (Nebivolol/Hydrochlorothiazide) based on frequency and the body system affected. The safety profile reflects the combined characteristics of a beta-blocker and a thiazide diuretic, encompassing cardiovascular, neurological, and metabolic domains.

Frequency-Classified Adverse Reactions

The following are examples of adverse reactions listed in regulatory documents, categorized by their approximate rate of occurrence:

  • Common Reactions: These may include headache, dizziness, fatigue, nausea, constipation, and slow heart rate (bradycardia).
  • Uncommon Reactions: Documented effects include sleep disturbances, depression, visual disturbances, and rash.
  • Rare Reactions: These reports include hypersensitivity reactions and angioedema.

Serious Adverse Reactions and Safety Restrictions

Official labels describe specific serious adverse reactions. The Hydrochlorothiazide component is associated with rare, severe effects such as Acute Myopia and Secondary Angle-Closure Glaucoma, and severe skin reactions like Stevens-Johnson Syndrome. Additionally, an increased risk of Non-melanoma skin cancer has been reported with long-term exposure to Hydrochlorothiazide.

The medication is subject to high-level contraindications defined in regulatory documents. It should not be used in individuals with severe hepatic impairment, severe renal failure, anuria, decompensated heart failure, cardiogenic shock, or conditions such as severe bradycardia and certain cardiac conduction blocks.

Population-Specific and Time-Related Safety

Safety statements include specific notes for patients with renal and hepatic impairment, as well as older adults. Furthermore, the regulatory safety notes specify that certain effects, such as bradycardia, may be more pronounced at the start of treatment. In contrast, electrolyte imbalances and metabolic changes are often associated with long-term exposure to the diuretic component.

Overdose and Emergency Response

Overdose and When to Seek Help

Any suspected overdose with the fixed-dose combination of Nebivolol (beta-blocker) and Hydrochlorothiazide (thiazide diuretic) requires immediate medical attention. The official regulatory profile describes manifestations arising from the dual pharmacology, including severe cardiovascular effects from the beta-blocker and critical fluid and electrolyte disturbances from the diuretic.

Documented Overdose Manifestations

System Documented Signs and Symptoms
Cardiovascular Bradycardia (slow heart rate), hypotension (low blood pressure), cardiac failure, and heart block (second or third degree).
Metabolic Severe hypokalemia (low potassium), hyponatremia (low sodium), and hypoglycemia. Clinical signs include weakness, lethargy, and muscle cramps.
Respiratory Bronchospasm (constriction of airways).

Required Emergency Actions

Seek immediate medical attention and contact emergency services for any suspected overdose. The regulatory labeling states that no specific antidote is known for Nebivolol overdose. Management must therefore be symptomatic and supportive, guided by the specific clinical manifestations presented by the patient.

Specific supportive treatments described in official documents include intravenous atropine and glucagon for cardiovascular symptoms, and correction of fluid and electrolyte abnormalities.

Therapeutic Uses of Hypoloc plus HCT

What Hypoloc plus HCT Treats: Main Uses and Benefits

The primary therapeutic use of Hypoloc plus HCT is the long-term management of essential hypertension (high blood pressure) in adult patients whose pressure is not adequately controlled by a single medication. It is applied when a dual approach is relevant to address both systemic fluid balance and cardiovascular factors contributing to persistently high systolic and diastolic blood pressure readings. Lowering blood pressure generally assists in reducing the likelihood of experiencing major cardiovascular events.

This medication is commonly used for conditions characterized by persistently elevated blood pressure, including cases of uncontrolled hypertension and hypertension requiring a fixed-dose combination strategy following the failure of monotherapy. Appropriate management supports the reduction of the accelerated cardiovascular risk profile, and may assist in reducing the potential for severe events, such as a stroke or heart attack, and supports the functional stability of vital organs like the brain, heart, and kidneys. This single-pill regimen supports patient adherence and consistency in their long-term therapeutic commitment.


Quick Fact: Relief for Uncontrolled Pressure Hypoloc plus HCT is commonly used when symptoms related to systemic imbalance and heightened physiological activity contribute to blood pressure readings remaining outside the target range, and supports the maintenance of functional stability.

Regulatory References

  1. NIH DailyMed overview

Eligibility and Restrictions for Use

Hypoloc plus HCT is officially indicated for the treatment of essential hypertension in adults whose blood pressure has already been demonstrated to be adequately controlled by the concurrent use of the two components (Nebivolol and Hydrochlorothiazide) as separate products.

Official Contraindications (Who Must Not Use)

Official regulatory labeling establishes absolute non-eligibility based on specific clinical states, primarily due to the properties of the beta-blocker and diuretic components:

  • Cardiac and Circulatory Conditions: Individuals with very slow heartbeat (severe bradycardia, heart rate less than 60 bpm prior to therapy), certain severe heart rhythm problems (like second and third-degree AV block or sick sinus syndrome without a pacemaker), acute heart failure, or severe peripheral circulatory disturbances.
  • Organ and Metabolic Function: Patients with severe renal insufficiency (creatinine clearance < 30 mL/min), anuria (absence of urine), or liver insufficiency or impaired liver function.
  • Hypersensitivity: Known allergy to the active ingredients, any excipient, or any other sulphonamide-derived substance.
  • Other Conditions: History of bronchospasm, bronchial asthma, untreated phaeochromocytoma, metabolic acidosis, and specific refractory electrolyte imbalances (such as hypokalaemia).

Age and Developmental Eligibility

Population Group Official Eligibility Status (Regulatory Labeling)
Children and Adolescents (under 18) Not recommended; safety and efficacy have not been established.
Older Adults (over 75) Use requires caution and close monitoring due to limited clinical experience.
Pregnancy Not recommended during pregnancy.
Lactation Not recommended for mothers who are breastfeeding.

These official statements define the groups for whom the medicine is not suitable, either as an absolute ban or under conditions where use is not recommended due to unestablished safety or known regulatory constraints.

What should I know about interactions with other medicines?

Hypoloc plus HCT contains nebivolol and hydrochlorothiazide, and therefore has potential interactions related to both components. Always inform your doctor or pharmacist about all prescription and non-prescription medicines, vitamins, supplements, and herbal products you are taking.


️ Medicines Requiring Close Monitoring or Avoidance

Certain combinations may increase the risk of serious side effects, such as very low blood pressure (hypotension), slow heart rate (bradycardia), or electrolyte imbalances.

Drug Class or Medicine Potential Effect of Interaction
Other Blood Pressure Medicines (e.g., other beta-blockers, ACE inhibitors, calcium channel blockers) Increased risk of very low blood pressure and slow heart rate.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (e.g., ibuprofen, naproxen) May reduce the blood pressure-lowering effect of Hypoloc plus HCT, and may increase the risk of kidney problems.
Lithium (used for mood disorders) Hydrochlorothiazide can increase lithium levels, leading to increased risk of toxicity.
Diabetes Medicines (e.g., insulin, metformin) Hydrochlorothiazide may make these medicines less effective by increasing blood sugar levels.
Cholestyramine or Colestipol (cholesterol-lowering agents) Can prevent the body from absorbing hydrochlorothiazide, making it less effective.
Corticosteroids (e.g., prednisone) Increased risk of low blood potassium (hypokalemia).
Narcotics/Opioids or Barbiturates Increased risk of orthostatic hypotension (dizziness upon standing).

Other Important Interactions

  • Alcohol can increase the hypotensive effects, leading to enhanced dizziness or lightheadedness.
  • If you have a history of severe allergic reactions or are undergoing desensitization therapy, nebivolol may increase sensitivity to allergens and reduce the effectiveness of adrenaline.
  • Hypoloc plus HCT may affect the results of certain laboratory tests, such as those for parathyroid function.

Your healthcare provider may need to adjust the doses of your medications or monitor you carefully for side effects if you are taking any of these products.

Mechanism of Action

Hypoloc plus HCT acts within distinct mechanistic domains to modulate key physiological pathways through the combined action of its two components.

Dual Adrenergic Receptor Modulation

This domain covers the engagement of alpha1 and beta-adrenergic receptors, initiating a signaling sequence that reduces sympathetic outflow's impact on target tissues. This mechanistic consequence attenuates the effect of heightened mediator activity (e.g., catecholamines) across the vascular and cardiac systems.


Renal Electrolyte Reabsorption Control

This mechanism operates within the kidney's tubule system, specifically through the inhibition of the Na^+/ Cl^- cotransporter in the distal convoluted tubule. This action modifies early molecular steps related to sodium handling, resulting in downstream adjustments to systemic physiology via altered fluid and electrolyte excretion.


Cardiac Performance and Renin Regulation

The compound modifies molecular steps by targeting beta1 receptors in myocardial tissue and the juxtaglomerular apparatus. This dual effect engages signaling sequences to modify downstream molecular flux, inducing adjustments toward a stabilized state within targeted pathways that modulate parameters associated with physiological overactivity.

Dosage and Administration Information

How to Use Hypoloc plus HCT

This section outlines the administration guidelines for the fixed-dose combination of Nebivolol and Hydrochlorothiazide.


Administration Scope

Field Labeled Instruction
Route of Administration Oral use as a film-coated tablet.
Standard Adult Dose One tablet daily (5 mg Nebivolol / 12.5 mg Hydrochlorothiazide).
Timing and Frequency Taken once daily, preferably at the same time of the day. The tablet can be taken with or without meals.
Treatment Context Indicated as replacement therapy for adult patients whose blood pressure is already adequately controlled on the two separate components given concurrently.

Procedural and Population Rules

Procedural Structure: The fixed-dose tablet is swallowed with some water. A score line is present only to facilitate breaking for ease of swallowing; it is not to be used to divide the tablet into equal doses, ensuring the correct ratio of active ingredients is administered.

Population-Specific Rules: Use of this fixed-dose combination is not recommended for the pediatric population (under 18 years) due to insufficient data on efficacy and safety. Use is contraindicated in patients with severe forms of hepatic insufficiency or severe renal impairment (creatinine clearance less than 30 mL/min). For older people (above 75 years), caution must be exercised and patients monitored closely.


These instructions establish the medication as a single, long-term maintenance treatment that mandates consistent daily adherence to the once-daily dosing schedule and the fixed ratio of the combined components.

Recent Clinical Evidence

Hypoloc plus HCT: Recent Clinical Evidence

Research has examined the efficacy and tolerability of the fixed-dose combination of nebivolol (a selective beta-blocker) and hydrochlorothiazide (HCT) (a thiazide diuretic) in the management of high blood pressure (hypertension).

Clinical trials have generally focused on the compound's effect on reducing blood pressure measurements, specifically Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP), over a typical duration of 12 weeks. These studies used changes in both office-measured and 24-hour ambulatory blood pressure monitoring as primary endpoints.

Findings in Special Populations

Studies have investigated the compound's use in specific patient groups who often have complex management needs, including:

  • Elderly Patients: Research has explored the use of the combination in older patients with isolated systolic hypertension, where a comparison was made against another common combination treatment.
  • Diabetic Patients: Analyses have been conducted to document the effects of the combination on blood pressure control in individuals with coexisting type 2 diabetes, monitoring for potential alterations in metabolic markers such as blood sugar and lipid levels.

Safety Monitoring

The safety profile is continually monitored through trials and post-marketing surveillance. Documented data from clinical studies include monitoring for adverse events, tracking changes in electrolytes (such as potassium and uric acid), and following cardiovascular parameters (e.g., heart rate and ECG changes). Longer-term extension studies document observed events and safety parameters over extended periods in smaller cohorts.

Frequently Asked Questions (FAQ)

Common questions about Hypoloc plus HCT (FAQ)


Q: How quickly should I expect Hypoloc plus HCT to start working?

The two components of the medicine start working at different times. The hydrochlorothiazide component is described as starting its pharmacological effect, such as increased urination, within about two hours. The full blood pressure-lowering effect of the combination builds over time, with the maximum benefit typically assessed after several weeks of consistent, daily use.

Q: Does Hypoloc plus HCT cure high blood pressure, or just manage it?

Hypoloc plus HCT is classified by regulatory bodies as an antihypertensive agent used for the long-term management of high blood pressure (essential hypertension). Like most blood pressure medicines, it is intended to help control and maintain blood pressure within a safer range as part of a continuous treatment plan, rather than providing a cure.

Q: What's the difference between Hypoloc and Hypoloc plus HCT?

Hypoloc generally refers to the single-ingredient product containing only nebivolol (the beta-blocker component). Hypoloc plus HCT is the fixed-dose combination product that contains both nebivolol and the diuretic, hydrochlorothiazide (HCT). The 'plus HCT' indicates the addition of the second medicine.

Q: What are the food restrictions to consider when taking Hypoloc plus HCT?

Official information states that the tablet can be taken with or without food. Because the hydrochlorothiazide component can potentially lead to a loss of potassium, official patient information often refers to the importance of maintaining a balanced diet, which may include foods rich in potassium.

Q: Can drinking grapefruit juice affect Hypoloc plus HCT?

Grapefruit and its juice can interfere with how the body processes some types of blood pressure medications. While not always listed specifically on the combination label, this is a known interaction to monitor for certain antihypertensives. Regulatory materials note that a healthcare provider may offer guidance about specific food or drink interactions.

Q: What are the long-term safety concerns associated with Hypoloc plus HCT?

The official documentation mentions a potential concern related to the long-term use of the hydrochlorothiazide component, which is an increased risk of developing Non-Melanoma Skin Cancer. Additionally, long-term safety monitoring involves regularly tracking changes in key body electrolytes, such as potassium and uric acid levels.

Q: Does Hypoloc plus HCT affect blood sugar levels?

Official warnings indicate that the medication may affect the body's metabolism and can potentially increase blood sugar levels. This effect may make existing diabetes medicines less effective. Metabolic monitoring, including blood sugar levels, is an expected component of patient care, particularly for individuals with co-existing conditions like diabetes.

Q: Can Hypoloc plus HCT cause muscle cramps?

Muscle cramps are a documented symptom of fluid or electrolyte imbalance, which is a known risk associated with the diuretic (hydrochlorothiazide) component. Other potential signs of imbalance documented in regulatory sources may include dry mouth, weakness, or muscular fatigue.

Q: What is the typical duration of treatment with Hypoloc plus HCT?

Hypoloc plus HCT is indicated for the treatment of essential hypertension, which is a chronic condition. Regulatory documents describe the drug as a long-term maintenance treatment to ensure consistent control over blood pressure.

Q: Can Hypoloc plus HCT affect my mood?

Official adverse reaction lists include reports of depression and other central nervous system effects such as sleep disturbances and nightmares, although these effects are categorized as uncommon. The nebivolol component is known to affect the central nervous system.

Q: Is a persistent cough a known side effect of Hypoloc plus HCT?

Official documents containing the side effect profile of this product do not typically list a persistent cough as a common or uncommon adverse reaction. This specific type of cough is more characteristic of a different class of blood pressure medicines (ACE inhibitors).

Q: Does Hypoloc plus HCT require regular blood tests?

Official patient information states that the medication can affect the levels of certain chemicals in your blood, called electrolytes. For safety monitoring, checking these levels, along with blood fat and uric acid, is a procedure that is often performed via a blood test.

Q: Why might a doctor switch me from two separate pills to Hypoloc plus HCT?

The fixed-dose combination is indicated as replacement therapy for adults whose blood pressure is already well-controlled on the two components (nebivolol and hydrochlorothiazide) taken separately. The primary regulatory rationale is to provide a simplified regimen to maintain consistent blood pressure control.

Q: Does Hypoloc plus HCT make me sensitive to the sun?

The hydrochlorothiazide component may cause the skin to become oversensitive to sunlight or artificial UV light, an effect known as photosensitivity. Regulatory materials highlight the importance of protecting the skin from sun exposure and UV rays while using this medication.

Q: Can Hypoloc plus HCT affect cholesterol readings?

Yes, official patient information notes that Hypoloc plus HCT may increase blood fat levels (lipids or cholesterol). These metabolic markers are among the parameters that may be monitored by a healthcare provider while a patient is taking the medicine.

Q: What is the risk of low blood pressure (hypotension) with Hypoloc plus HCT?

Low blood pressure (hypotension) is a known, though uncommon, adverse reaction and risk, particularly when treatment is first started or the dose is adjusted. Symptoms that may indicate low blood pressure include dizziness, fainting, or significant weakness.

Q: Is there a link between Hypoloc plus HCT and skin rashes?

Yes, rash is listed as an uncommon adverse reaction in official documents. Furthermore, the hydrochlorothiazide component is associated with very rare, severe skin reactions, including conditions like Stevens-Johnson Syndrome.

Q: What happens in the body when Hypoloc plus HCT is working?

The medicine works in two main ways to reduce blood pressure. The nebivolol part helps control heart rate and pumping strength. The hydrochlorothiazide part acts as a diuretic, increasing the amount of urine produced to help reduce excess fluid and pressure in the blood vessels.

Q: Does Hypoloc plus HCT cause changes in urine output?

Yes, the hydrochlorothiazide component is a diuretic, often referred to as a 'water pill.' Its action is to increase the amount of urine produced. It is generally described that patients may notice an increase in their urine output, especially soon after starting the medication.

Q: Can Hypoloc plus HCT be crushed or split?

The tablet may have a score line present, but this is only to make it easier to swallow, and not to divide the tablet into equal doses. Official regulatory documents do not provide instruction for crushing, so the tablet should be swallowed whole or split only for ease of swallowing.

Q: Is Hypoloc plus HCT used for conditions other than hypertension?

The official therapeutic indication for the fixed-dose combination product, Hypoloc plus HCT, is strictly the treatment of essential hypertension (high blood pressure) in adults. Regulatory documents do not list other primary uses for this combination.

Q: Is it true that Hypoloc plus HCT is used for heart failure in addition to high blood pressure?

The combination product is officially indicated only for hypertension. While the single-ingredient nebivolol product has been studied and used for heart failure in some countries, the combination product is officially contraindicated (must not be used) in patients with uncontrolled or decompensated heart failure.

Q: Is Hypoloc plus HCT associated with changes in eyesight?

Yes, official adverse reaction lists include uncommon reports of visual disturbances. The hydrochlorothiazide component is also associated with rare, severe effects such as a decrease in vision or eye pain, which may be symptoms of fluid accumulation in the eye or an increase in eye pressure.

Q: Does Hypoloc plus HCT affect sleep?

Yes, the official list of uncommon adverse reactions includes reports of sleep disturbances and nightmares. These effects are linked to the nebivolol component and its activity in the central nervous system.

How should Hypoloc plus HCT be stored and disposed of?

How to Store and Dispose of Hypoloc plus HCT

Storage and disposal must strictly adhere to regulatory requirements to ensure product integrity and public safety.

Storage Conditions

  • Temperature: Store at Controlled Room Temperature, specifically between 20° to 25°C (68° to 77°F).
  • Protection: The tablets must be protected from light and moisture. The container must be kept tightly closed.
  • Prohibited Environments: The medication must be kept from freezing and should not be stored in extremely cold conditions.
  • Child Safety: All medicine must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Hypoloc plus HCT should be disposed of according to local requirements for medicinal waste. Do not dispose of the tablets by placing them in household trash or pouring them into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hypoloc plus HCT found in:

A-Z Index: